Nontuberculous mycobacteria: Defining disease in a prospective cohort of South African miners

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 1, 1999, Pages 15-21

  Corbett, Elizabeth L ^a   Blumberg, Lucille ^b   Churchyard, Gavin J ^b   Moloi, Nomsa ^b   Mallory, Kathy ^b   Clayton, Tim ^b   Williams, Brian G ^b   Chaisson, Richard E ^b   Hayes, Richard J ^b   De Cock, Kevin M ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIUM ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MINER; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM SCROFULACEUM; PRIORITY JOURNAL; RADIODIAGNOSIS; TREATMENT OUTCOME;

EID: 0032783342     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.1.9812080     Document Type: Article

References (25)

1. Corbett, E. L., G. J. Churchyard, T, Moyake, P. Herselman, T. Clayton, B. Williams, D. Mulder, R. Hayes, and K. M. De Cock. 1998. HIV infection, silicosis and mycobacterial disease incidence in South African miners. Int. J. Tuberc. Lung. Dis. 2:S301.
2. Corbett, E. L., G. I. Churchyard, T. Clayton, P. Herselman, B. Williams, R. Hayes, D. Mulder, and K. M. De Cock. 1999. Risk factors for pulmonary mycobacterial disease in South African gold miners: a case-control study. Am. J. Respir. Crit. Care Med. 159:94-99.
3. American Thoracic Society, 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156(Suppl.):S1-25.
4. Runyon, E. H. 1970. Identification of mycobacterial pathogens utilising colony characteristics. Am. J. Clin. Pathol. 54:578-586.
5. Kubica, G. P. 1973. Differential identification of mycobacteria: VII. Key features of identification of clinically significant mycobacteria. Am. Rev. Respir. Dis. 107:9-12.
6. Wolinsky, E. 1979. Nontuberculous mycobacteria and associated diseases. Am. Rev. Respir. Dis. 199:107-159.
7. Falkinham, J. O. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev. 9:177-212.
8. British Thoracic Society, Research Committee. 1994. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months treatment with rifampicin and ethambutol. Thorax 49:442-445.
9. Policard, A., C. H. Gernez-Ricux, A. Tacquet, J. C. Marlin, B. Devulder, and L. Le Bouffant. 1967. Influence of pulmonary dust load on the development of experimental infection by Mycobacterium kansasii. Nature 216:177-178.
10. Rigsby, M. O., and A. M. Curtis. 1994. Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus. Chest 106:913-919.
11. Lillo, M., S. Orengo, P. Ceroch, and R. L. Harris, 1990. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience, Rev. Infect. Dis. 12:760-767.
12. Levine, B., and R. E. Chaisson. 1991. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus infection. Ann. Intern. Med. 114:861-868.
13. Carpenter, J. L., and J. M. Parks. 1991. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev. Infect. Dis. 13:788-796.
14. Valainis, G. T., L. M. Cardona, and D. L. Greer. 1991. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J. Acquir. Immune Defic. Syndr. 4:516-520.
15. Bamberger, D, M., M. R. Driks, M. R. Gupta, M. C. O'Connor, P. M. Jost, R. E. Neihart, D. S. McKinsey, I., A. Moore, and the Kansas City AIDS Research Consortium. 1994. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin. Infect. Dis. 18:395-400.
16. Witzig, R. S., B. A. Fazal, R. M. Mera, D. M. Mushatt, P. M. J. T. Dejace, D. L. Greer, and N. E. Hyslop. 1995. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus. Clin. Infect. Dis. 21:77-85.
17. Campo, R. E., and C. E. Campo. 1997. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24:1233-1238.
18. Corbett, E. L., G. J. Churchyard, M. Hay, P. Herselman, C. Clayton, B. Williams, R. Hayes, D. Mulder, and K. M. De Cock. 1999. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am. J. Respir. Crit. Care Med. 160:10-14.
19. Jones, B. E., S. M. M. Young, D. Antoniskis, P. T. Davidson, F. Kramer, and P. F. Barnes. 1993. Relationship of the manifestations of tuberculosis to CD4 cells counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 148:1292-1297.
20. Abouya, L., I. M. Coulibaly, D. Coulibaly, S. Kassim, A. Ackah, A. E. Greenberg, S. Z. Wiktor, and K. M. De Cock. 1995. Radiological manifestations of pulmonary tuberculosis in HIV-1 and HIV-2-infected patients in Abidjan, Cote d'Ivoire. Tuberc. Lung Dis. 76:436-440.
21. O'Brien, R. J., I. J. Geiter, and D. E. Snider. 1987. The epidemiology of nontuberculous mycobacterial disease in the United States: results from a national survey. Am. Rev. Respir. Dis. 135:1007-1014.
22. Evans, S. A., A. Colville, A. J. Evans, A. J. Crisp, and D. A. Johnston. 1996. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcomes with pulmonary tuberculosis. Thorax 51:1248-1252.
23. Choudhri, S., J. Manfreda, J. Wolfe, S. Parker, and R. Long. 1995. Clinical significance of nontuberculous mycobacterial isolates in a Canadian tertiary care center. Clin. Infect. Dis. 21:128-133.
24. Bloch, K. C., L. Zwerling, M. J. Pletcher, J. A. Hahn, J. L. Gerherding, S. M. Ostroff, T. J. Vulga, and A. I. Reingold. 1998. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5 year, population based study. Ann. Intern. Med. 129:698-704.
25. Ahn, C. H., J. W. McLarty, S. S. Ahn, I. Ahn, and G. A. Hurst. 1982. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am. Rev. Respir. Dis. 125:388-391.